Skip to main content
. 2021 Nov 28;13(23):5987. doi: 10.3390/cancers13235987

Table 5.

LncRNAs and meningioma (ANTs: adjacent non-tumor samples).

lncRNA Accession Number/Location Pattern of Expression Clinical Samples/Animal Model Assessed Cell Lines Targets/Regulators Signaling Pathways Description Reference
SNHG1 ENSG00000255717/11q12.3 - CH157-MN, HBL-52, BEN-MEN-1,
IOMM-Lee
miR-556-5p↓, TCF12↑/TCF12 Wnt/β-catenin SNHG1 overexpression, indicated by qRT-PCR, has a marked impact on elevating cell proliferation and growth rates and inhibiting apoptosis. [36]
LINC00702 ENSG00000233117/10p15.1 88 malignant meningioma and ANTs OMM-Lee, KT21, CH157-MN, HBL-52, Ben-Men-1 miR-4652-3p↓, ZEB1↑ Wnt/β-catenin This lncRNA overexpression, as formerly showed by qRT-PCR, has a significant correlation with a lower OS rate. Cell migration and proliferation are positively associated with its expression. [65]
LINC00460 ENSG00000233532/13q33.2 33 meningioma and 10 normal meninges tissues IOMM-Lee, CH157-MN, Ben-Men-1 miR-539↓, MMP-2↑, MMP-9↑, ZEB1↑ - LINC00460 escalates cell invasion and proliferation and lowers the apoptosis rate. qRT-PCR was used to evaluate this lncRNA’s expression. [35]
MEG3 ENSG00000214548/14q32.2 5 healthy meninges and 32 meningioma tissues (IOMM-Lee, CH157-MN miR-29c↑, AKAP12↓ - qRT-PCR showed MEG3 downregulation in tumor tissues. Cell cycle progression, proliferation, migration, and invasion are negatively correlated with MEG3 expression. [66]